AFN-1252 tosylate is an orally active, selective FabI inhibitor used for the treatment of Staphylococcus infections; it demonstrates potent activity against various clinical isolates of Staphylococcus aureus with MIC90 values ≤0.015 μg/mL; it is effective in a murine sepsis model, providing 100% protection against lethal peritoneal infection caused by Staphylococcus aureus.